This week learn more about CDC's strategies to reduce waterborne diseases; the US change to a trivalent influenza vaccine; new data for Merck's pneumococcal vaccine; and how PCR testing can influence a patient diagnosis and outcome.
The Latest in Clostridioides difficile Research and News
C difficile, Antimicrobials, and the Patients Most Affected
Oral Vancomycin Reduces CDI by 64% in Stem Cell Transplant Patients
Top 5 Infectious Disease News Stories Week of November 8-15
Head-to-Head Comparison of Treatments for Recurrent C difficile Infection
Top 5 Infectious Disease New Stories Week of November 2-8